What is the current valuation of the Gastric Bypass Market as of 2024?

The Gastric Bypass Market was valued at approximately 2665.61 USD Million in 2024. Read More

What is the projected market valuation for the Gastric Bypass Market in 2035?

The market is projected to reach approximately 4957.04 USD Million by 2035. Read More

What is the expected CAGR for the Gastric Bypass Market during the forecast period 2025 - 2035?

The expected CAGR for the Gastric Bypass Market during the forecast period 2025 - 2035 is 5.76%. Read More

Which surgical procedure type holds the highest market value in the Gastric Bypass Market?

The Roux-en-Y Gastric Bypass procedure held the highest market value at approximately 1980.0 USD Million. Read More

How does the market value for Obesity Class III patients compare to other obesity classes?

The market value for Obesity Class III patients is projected to be around 2500.0 USD Million, indicating a substantial share. Read More

What are the projected market values for different surgical techniques in the Gastric Bypass Market?

Laparoscopic Surgery is projected to dominate with values reaching up to 2980.0 USD Million. Read More

Which healthcare setting is expected to have the highest market valuation in the Gastric Bypass Market?

Hospitals are expected to have the highest market valuation, projected at around 2200.0 USD Million. Read More

What are the anticipated postoperative complications and their market values?

Nutritional Deficiencies are projected to have a market value of approximately 1000.0 USD Million. Read More

Who are the key players in the Gastric Bypass Market?

Key players include Johnson & Johnson, Medtronic, and Boston Scientific, among others. Read More

What is the market value range for Sleeve Gastrectomy procedures?

The market value for Sleeve Gastrectomy procedures is projected to range from 800.0 to 1500.0 USD Million. Read More

Gastric Bypass Market

ID: MRFR/MED/3878-HCR

105 Pages

Vikita Thakur

Last Updated: May 15, 2026

Gastric Bypass Market Research Report Information By Type (Endoscopic Sleeve Gastroplasty, Intragastric Balloon), Indication (Gastroesophageal Reflux Disease, Heart Disease, Type 2 Diabetes), End User (Hospitals, Surgical Centers) - Forecast till 2035

Gastric Bypass Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)5.76%

2024 Market Size$ 2,665.61 Million

2025 Market Size$ 2,849.69 Million

2035 Market Size$ 4,957.04 Million

Key Players

Johnson & Johnson

Medtronic

Boston Scientific

Stryker

B. Braun Melsungen AG

Ethicon

Trends

Rising Obesity Rates
Technological Advancements
Demographic Shifts

Opportunities

Rising Obesity Rates
Market Growth Projections
Supportive Healthcare Policies

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Surgical Procedure Type (USD Million) | |
  1. 4.1.1 Roux-en-Y Gastric Bypass | |
  2. 4.1.2 Sleeve Gastrectomy | |
  3. 4.1.3 Biliopancreatic Diversion | |
  4. 4.1.4 Adjustable Gastric Banding |
2. 4.2 Healthcare, BY Patient Demographics (USD Million) | |
  1. 4.2.1 Obesity Class I | |
  2. 4.2.2 Obesity Class II | |
  3. 4.2.3 Obesity Class III | |
  4. 4.2.4 Age Group 18-35 | |
  5. 4.2.5 Age Group 36-50 |
3. 4.3 Healthcare, BY Postoperative Complications (USD Million) | |
  1. 4.3.1 Nutritional Deficiencies | |
  2. 4.3.2 Dumping Syndrome | |
  3. 4.3.3 Gastroesophageal Reflux Disease | |
  4. 4.3.4 Surgical Site Infections |
4. 4.4 Healthcare, BY Surgical Techniques (USD Million) | |
  1. 4.4.1 Laparoscopic Surgery | |
  2. 4.4.2 Open Surgery | |
  3. 4.4.3 Robotic Surgery |
5. 4.5 Healthcare, BY Healthcare Setting (USD Million) | |
  1. 4.5.1 Hospital | |
  2. 4.5.2 Ambulatory Surgical Center | |
  3. 4.5.3 Specialty Clinic |
6. 4.6 Healthcare, BY Region (USD Million) | |
  1. 4.6.1 North America | | |
    1. 4.6.1.1 US | | |
    2. 4.6.1.2 Canada | |
  2. 4.6.2 Europe | | |
    1. 4.6.2.1 Germany | | |
    2. 4.6.2.2 UK | | |
    3. 4.6.2.3 France | | |
    4. 4.6.2.4 Russia | | |
    5. 4.6.2.5 Italy | | |
    6. 4.6.2.6 Spain | | |
    7. 4.6.2.7 Rest of Europe | |
  3. 4.6.3 APAC | | |
    1. 4.6.3.1 China | | |
    2. 4.6.3.2 India | | |
    3. 4.6.3.3 Japan | | |
    4. 4.6.3.4 South Korea | | |
    5. 4.6.3.5 Malaysia | | |
    6. 4.6.3.6 Thailand | | |
    7. 4.6.3.7 Indonesia | | |
    8. 4.6.3.8 Rest of APAC | |
  4. 4.6.4 South America | | |
    1. 4.6.4.1 Brazil | | |
    2. 4.6.4.2 Mexico | | |
    3. 4.6.4.3 Argentina | | |
    4. 4.6.4.4 Rest of South America | |
  5. 4.6.5 MEA | | |
    1. 4.6.5.1 GCC Countries | | |
    2. 4.6.5.2 South Africa | | |
    3. 4.6.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Johnson & Johnson (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Medtronic (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Boston Scientific (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Stryker (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 B. Braun Melsungen AG (DE) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Ethicon (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Intuitive Surgical (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Conmed Corporation (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Hologic (US) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
7. 6.4 US MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
8. 6.5 US MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
9. 6.6 US MARKET ANALYSIS BY SURGICAL TECHNIQUES |
10. 6.7 US MARKET ANALYSIS BY HEALTHCARE SETTING |
11. 6.8 CANADA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
12. 6.9 CANADA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
13. 6.10 CANADA MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
14. 6.11 CANADA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
15. 6.12 CANADA MARKET ANALYSIS BY HEALTHCARE SETTING |
16. 6.13 EUROPE MARKET ANALYSIS |
17. 6.14 GERMANY MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
18. 6.15 GERMANY MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
19. 6.16 GERMANY MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
20. 6.17 GERMANY MARKET ANALYSIS BY SURGICAL TECHNIQUES |
21. 6.18 GERMANY MARKET ANALYSIS BY HEALTHCARE SETTING |
22. 6.19 UK MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
23. 6.20 UK MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
24. 6.21 UK MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
25. 6.22 UK MARKET ANALYSIS BY SURGICAL TECHNIQUES |
26. 6.23 UK MARKET ANALYSIS BY HEALTHCARE SETTING |
27. 6.24 FRANCE MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
28. 6.25 FRANCE MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
29. 6.26 FRANCE MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
30. 6.27 FRANCE MARKET ANALYSIS BY SURGICAL TECHNIQUES |
31. 6.28 FRANCE MARKET ANALYSIS BY HEALTHCARE SETTING |
32. 6.29 RUSSIA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
33. 6.30 RUSSIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
34. 6.31 RUSSIA MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
35. 6.32 RUSSIA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
36. 6.33 RUSSIA MARKET ANALYSIS BY HEALTHCARE SETTING |
37. 6.34 ITALY MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
38. 6.35 ITALY MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
39. 6.36 ITALY MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
40. 6.37 ITALY MARKET ANALYSIS BY SURGICAL TECHNIQUES |
41. 6.38 ITALY MARKET ANALYSIS BY HEALTHCARE SETTING |
42. 6.39 SPAIN MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
43. 6.40 SPAIN MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
44. 6.41 SPAIN MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
45. 6.42 SPAIN MARKET ANALYSIS BY SURGICAL TECHNIQUES |
46. 6.43 SPAIN MARKET ANALYSIS BY HEALTHCARE SETTING |
47. 6.44 REST OF EUROPE MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
48. 6.45 REST OF EUROPE MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
49. 6.46 REST OF EUROPE MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
50. 6.47 REST OF EUROPE MARKET ANALYSIS BY SURGICAL TECHNIQUES |
51. 6.48 REST OF EUROPE MARKET ANALYSIS BY HEALTHCARE SETTING |
52. 6.49 APAC MARKET ANALYSIS |
53. 6.50 CHINA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
54. 6.51 CHINA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
55. 6.52 CHINA MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
56. 6.53 CHINA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
57. 6.54 CHINA MARKET ANALYSIS BY HEALTHCARE SETTING |
58. 6.55 INDIA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
59. 6.56 INDIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
60. 6.57 INDIA MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
61. 6.58 INDIA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
62. 6.59 INDIA MARKET ANALYSIS BY HEALTHCARE SETTING |
63. 6.60 JAPAN MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
64. 6.61 JAPAN MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
65. 6.62 JAPAN MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
66. 6.63 JAPAN MARKET ANALYSIS BY SURGICAL TECHNIQUES |
67. 6.64 JAPAN MARKET ANALYSIS BY HEALTHCARE SETTING |
68. 6.65 SOUTH KOREA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
69. 6.66 SOUTH KOREA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
70. 6.67 SOUTH KOREA MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
71. 6.68 SOUTH KOREA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
72. 6.69 SOUTH KOREA MARKET ANALYSIS BY HEALTHCARE SETTING |
73. 6.70 MALAYSIA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
74. 6.71 MALAYSIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
75. 6.72 MALAYSIA MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
76. 6.73 MALAYSIA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
77. 6.74 MALAYSIA MARKET ANALYSIS BY HEALTHCARE SETTING |
78. 6.75 THAILAND MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
79. 6.76 THAILAND MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
80. 6.77 THAILAND MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
81. 6.78 THAILAND MARKET ANALYSIS BY SURGICAL TECHNIQUES |
82. 6.79 THAILAND MARKET ANALYSIS BY HEALTHCARE SETTING |
83. 6.80 INDONESIA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
84. 6.81 INDONESIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
85. 6.82 INDONESIA MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
86. 6.83 INDONESIA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
87. 6.84 INDONESIA MARKET ANALYSIS BY HEALTHCARE SETTING |
88. 6.85 REST OF APAC MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
89. 6.86 REST OF APAC MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
90. 6.87 REST OF APAC MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
91. 6.88 REST OF APAC MARKET ANALYSIS BY SURGICAL TECHNIQUES |
92. 6.89 REST OF APAC MARKET ANALYSIS BY HEALTHCARE SETTING |
93. 6.90 SOUTH AMERICA MARKET ANALYSIS |
94. 6.91 BRAZIL MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
95. 6.92 BRAZIL MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
96. 6.93 BRAZIL MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
97. 6.94 BRAZIL MARKET ANALYSIS BY SURGICAL TECHNIQUES |
98. 6.95 BRAZIL MARKET ANALYSIS BY HEALTHCARE SETTING |
99. 6.96 MEXICO MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
100. 6.97 MEXICO MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
101. 6.98 MEXICO MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
102. 6.99 MEXICO MARKET ANALYSIS BY SURGICAL TECHNIQUES |
103. 6.100 MEXICO MARKET ANALYSIS BY HEALTHCARE SETTING |
104. 6.101 ARGENTINA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
105. 6.102 ARGENTINA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
106. 6.103 ARGENTINA MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
107. 6.104 ARGENTINA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
108. 6.105 ARGENTINA MARKET ANALYSIS BY HEALTHCARE SETTING |
109. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
110. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
111. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
112. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
113. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY HEALTHCARE SETTING |
114. 6.111 MEA MARKET ANALYSIS |
115. 6.112 GCC COUNTRIES MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
116. 6.113 GCC COUNTRIES MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
117. 6.114 GCC COUNTRIES MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
118. 6.115 GCC COUNTRIES MARKET ANALYSIS BY SURGICAL TECHNIQUES |
119. 6.116 GCC COUNTRIES MARKET ANALYSIS BY HEALTHCARE SETTING |
120. 6.117 SOUTH AFRICA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
121. 6.118 SOUTH AFRICA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
122. 6.119 SOUTH AFRICA MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
123. 6.120 SOUTH AFRICA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
124. 6.121 SOUTH AFRICA MARKET ANALYSIS BY HEALTHCARE SETTING |
125. 6.122 REST OF MEA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
126. 6.123 REST OF MEA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
127. 6.124 REST OF MEA MARKET ANALYSIS BY POSTOPERATIVE COMPLICATIONS |
128. 6.125 REST OF MEA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
129. 6.126 REST OF MEA MARKET ANALYSIS BY HEALTHCARE SETTING |
130. 6.127 KEY BUYING CRITERIA OF HEALTHCARE |
131. 6.128 RESEARCH PROCESS OF MRFR |
132. 6.129 DRO ANALYSIS OF HEALTHCARE |
133. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
134. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
135. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE |
136. 6.133 HEALTHCARE, BY SURGICAL PROCEDURE TYPE, 2024 (% SHARE) |
137. 6.134 HEALTHCARE, BY SURGICAL PROCEDURE TYPE, 2024 TO 2035 (USD Million) |
138. 6.135 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE) |
139. 6.136 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million) |
140. 6.137 HEALTHCARE, BY POSTOPERATIVE COMPLICATIONS, 2024 (% SHARE) |
141. 6.138 HEALTHCARE, BY POSTOPERATIVE COMPLICATIONS, 2024 TO 2035 (USD Million) |
142. 6.139 HEALTHCARE, BY SURGICAL TECHNIQUES, 2024 (% SHARE) |
143. 6.140 HEALTHCARE, BY SURGICAL TECHNIQUES, 2024 TO 2035 (USD Million) |
144. 6.141 HEALTHCARE, BY HEALTHCARE SETTING, 2024 (% SHARE) |
145. 6.142 HEALTHCARE, BY HEALTHCARE SETTING, 2024 TO 2035 (USD Million) |
146. 6.143 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
147. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
148. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.2.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.2.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.2.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.2.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
149. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.3.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.3.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.3.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.3.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
150. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.4.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.4.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.4.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.4.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
151. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.5.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.5.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.5.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.5.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
152. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.6.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.6.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.6.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.6.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
153. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.7.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.7.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.7.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.7.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
154. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.8.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.8.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.8.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.8.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
155. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.9.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.9.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.9.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.9.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
156. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.10.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.10.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.10.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.10.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
157. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.11.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.11.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.11.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.11.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
158. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.12.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.12.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.12.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.12.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
159. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.13.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.13.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.13.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.13.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
160. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.14.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.14.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.14.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.14.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
161. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.15.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.15.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.15.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.15.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
162. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.16.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.16.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.16.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.16.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
163. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.17.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.17.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.17.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.17.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
164. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.18.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.18.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.18.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.18.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
165. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.19.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.19.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.19.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.19.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
166. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.20.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.20.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.20.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.20.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
167. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.21.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.21.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.21.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.21.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
168. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.22.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.22.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.22.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.22.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
169. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.23.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.23.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.23.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.23.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
170. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.24.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.24.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.24.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.24.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
171. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.25.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.25.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.25.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.25.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
172. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.26.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.26.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.26.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.26.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
173. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.27.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.27.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.27.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.27.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
174. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.28.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.28.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.28.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.28.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
175. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.29.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.29.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.29.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.29.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
176. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Million) | |
  2. 7.30.2 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million) | |
  3. 7.30.3 BY POSTOPERATIVE COMPLICATIONS, 2025-2035 (USD Million) | |
  4. 7.30.4 BY SURGICAL TECHNIQUES, 2025-2035 (USD Million) | |
  5. 7.30.5 BY HEALTHCARE SETTING, 2025-2035 (USD Million) |
177. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
178. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Gastric Bypass Market Segmentation

Gastric Bypass Market By Surgical Procedure Type (USD Million, 2025-2035)

Roux-en-Y Gastric Bypass
Sleeve Gastrectomy
Biliopancreatic Diversion
Adjustable Gastric Banding

Gastric Bypass Market By Patient Demographics (USD Million, 2025-2035)

Obesity Class I
Obesity Class II
Obesity Class III
Age Group 18-35
Age Group 36-50

Gastric Bypass Market By Postoperative Complications (USD Million, 2025-2035)

Nutritional Deficiencies
Dumping Syndrome
Gastroesophageal Reflux Disease
Surgical Site Infections

Gastric Bypass Market By Surgical Techniques (USD Million, 2025-2035)

Laparoscopic Surgery
Open Surgery
Robotic Surgery

Gastric Bypass Market By Gastric Bypass Market Setting (USD Million, 2025-2035)

Hospital
Ambulatory Surgical Center
Specialty Clinic

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”